China Universal Asset Management Company’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Buy |
38,467
+458
| +1% | +$1.42K | 0.01% | 350 |
|
|
2025
Q1 | $133K | Sell |
38,009
-2,170
| -5% | -$7.57K | 0.01% | 344 |
|
|
2024
Q4 | $131K | Buy |
40,179
+3,870
| +11% | +$12.7K | 0.01% | 366 |
|
|
2024
Q3 | $140K | Buy |
36,309
+14,138
| +64% | +$54.4K | 0.02% | 326 |
|
|
2024
Q2 | $68.5K | Sell |
22,171
-10,062
| -31% | -$31.1K | 0.01% | 331 |
|
|
2024
Q1 | $83.2K | Buy |
32,233
+12,833
| +66% | +$33.1K | 0.01% | 389 |
|
|
2023
Q4 | $48.5K | Buy |
19,400
+15,104
| +352% | +$37.8K | 0.01% | 373 |
|
|
2023
Q3 | $8.72K | Buy |
4,296
+2,119
| +97% | +$4.3K | ﹤0.01% | 356 |
|
|
2023
Q2 | $5.01K | Buy |
2,177
+57
| +3% | +$131 | ﹤0.01% | 367 |
|
|
2023
Q1 | $6.42K | Buy |
2,120
+530
| +33% | +$1.61K | ﹤0.01% | 342 |
|
|
2022
Q4 | $3.71K | Buy |
1,590
+186
| +13% | +$433 | ﹤0.01% | 332 |
|
|
2022
Q3 | $3K | Buy |
+1,404
| New | +$3K | ﹤0.01% | 315 |
|